CLINICAL STUDY PROTOCOL X16069 Phase I/II Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma Indication: Relapsed/Refractory multiple myeloma Phase: Phase I/II Protocol History Original 10/10/2014 Amendment 1 10/02/2015 Amendment 2 03/21/2016 Amendment 3 06/01/2016 Amendment 4 10/06/2016 Amendment 5 02/14/2017 Amendment 6 08-28-2017 Confidentiality Statement: This protocol may not be used, published or otherwise disclosed without the written consent of the Medical College of Wisconsin Investigator and Study Center: Parameswaran Hari, MD, MRCP, MS Professor Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin 9200 W. Wisconsin Ave. Milwaukee, WI 53226 414.805.4600 Email address:
[email protected] Co-Investigator: Binod Dhakal, MD, MS Assistant Professor of Medicine Division of Hematology and Oncology Medical College of Wisconsin 9200 W. Wisconsin Ave. Milwaukee, WI 53226 414.805.4600 Sub-I: Ehab Atallah, MD Associate Professor Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin 9200 W. Wisconsin Ave. Milwaukee, WI 53226 414.805.4600 Sub-I: Timothy Fenske, MD Associate Professor Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin 9200 W. Wisconsin Ave. Milwaukee, WI 53226 414.805.4600 Sub-I: Laura Michaelis, MD Associate Professor Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin 9200 W. Wisconsin Ave. Milwaukee, WI 53226 414.805.4600 2 Sub-I: Karen-Sue Carlson, MD Assistant Professor Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin 9200 W.